Shares of Aurobindo Pharma surged almost 6 per cent in early trade on Thursday, despite reporting a decline in net profit for the latest June quarter. Better visibility in earnings growth in the coming quarters found favour with investors. However, as the initial euphoria waned, the stock ended almost flat compared to the previous day’s close. The company’s consolidated net profit for the f...